CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life Bridging the Gap Between Epigenetic and Genetic in PAH Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure Cardiovascular effects of radiation therapy Long-Term Durability of Transcatheter Heart Valves: Insights From Bench Testing to 25 Years Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies

ConsensusOctober 10, 2017, Volume 136, Issue 15

JOURNAL:Circulation. Article Link

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

AHA Scientific Statements Keywords: AHA Scientific Statements; delivery of health care; disease management; shock, cardiogenic

ABSTRACT

Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure. Despite improving survival in recent years, patient morbidity and mortality remain high, and there are few evidence-based therapeutic interventions known to clearly improve patient outcomes. This scientific statement on cardiogenic shock summarizes the epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock; reviews contemporary best medical, surgical, mechanical circulatory support, and palliative care practices; advocates for the development of regionalized systems of care; and outlines future research priorities.